RSS - Posts
Clinical trial findings show a light-activated disinfectant process kills SARS-CoV-2 viruses in the nose causing Covid-19 infections without harming nasal tissue. . . . → Read More: Light-Activated Treatment Kills Covid-19 Nasal Viruses
|
|||||
      |
Three new venture funds are seeking to invest up to $6.3 billion in start-up companies with advances in life sciences, health care, energy, and information technologies. . . . → Read More: New Venture Funds to Back Life Science, Tech Start-Ups  Leave a comment  Finance, Joint ventures/collaborations  Asia, biomedical, biotechnology, chemistry, computer science, energy, engineering, entrepreneurs, equity, investment, Japan, life sciences, materials science, mathematics, medical device, pharmaceuticals, physical sciences, software, venture capital 
A biotechnology company creating products for gut health and a university immunology lab are evaluating cleaning products for potential damage to human protective tissues. . . . → Read More: Biotech, Academic Lab Partner on Microbiome-Safe Products 
A vaccine against gonorrhea given as a nasal spray is shown to generate protective immune responses in lab mice of both sexes, and in females similar to an intravaginal vaccine. . . . → Read More: Nasal Spray Vaccine Shown to Stop Gonorrhea Infections Comments are closed Joint ventures/collaborations, New products biomedical, biotechnology, chemistry, Europe, licensing, life sciences, NIH, pharmaceuticals, physical sciences, preclinical, university 
A new company developing diagnostics for neurological and other disorders based on environmental exposures is raising $16 million in venture funds. . . . → Read More: Environmental Biomarker Start-Up Gains $16M in Early Funds One comment - (Comments are closed) Finance, New products biomedical, biotechnology, chemistry, entrepreneurs, equity, FDA, investment, licensing, life sciences, mathematics, medical device, physical sciences, physics, robotics, university, venture capital 
An international health organization is evaluating a new type of vaccine made with biodegradable RNA nanoparticles to help head off future viral pandemics. . . . → Read More: CEPI Assessing Advanced RNA Nanoparticle Vaccine One comment - (Comments are closed) Finance, Joint ventures/collaborations biomedical, biotechnology, chemistry, Covid-19, entrepreneurs, Europe, genomics, grant, life sciences, nanotechnology, pharmaceuticals, physical sciences, university 
A bioengineering team devised techniques for feasibly adding cancer-killing enzymes to engineered immune cells that in lab mice kill solid-tumor and blood cancer cells. . . . → Read More: Nanotech Enzyme Process Boosts T-Cell Cancer Therapies Comments are closed New products biomedical, biotechnology, cancer, chemistry, engineering, life sciences, manufacturing, materials science, nanotechnology, pharmaceuticals, physical sciences, preclinical, university 
A partnership of biotechnology components and therapy companies aims to develop new drugs made from circular forms of RNA, starting with a colorectal cancer treatment. . . . → Read More: Biotech Alliance Creating Circular RNA Cancer Drug Comments are closed Joint ventures/collaborations, New products biomedical, biotechnology, cancer, chemistry, engineering, genomics, life sciences, nanotechnology, pharmaceuticals, physical sciences 
An enterprise discovering new drugs with optical light-based protein chemistry is emerging from stealth, including work with biopharmaceutical company Genentech. . . . → Read More: Protein Chemistry Biotech Gains Collaboration, Venture Funds 2 comments - (Comments are closed) Finance, Joint ventures/collaborations, New products biomedical, biotechnology, cancer, chemistry, entrepreneurs, equity, investment, life sciences, mathematics, pharmaceuticals, physical sciences, preclinical, university 
A new enterprise is formed to develop gene-editing therapies for mitochondrial disorders, rare inherited mutations in the energy centers of cells. . . . → Read More: Company Started for Gene Editing Rare Inherited Diseases |
||||
|
Copyright © 2023 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||